These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Dosimetry in targeted alpha therapy. A systematic review: current findings and what is needed. Tronchin S; Forster JC; Hickson K; Bezak E Phys Med Biol; 2022 Apr; 67(9):. PubMed ID: 35316802 [No Abstract] [Full Text] [Related]
6. Targeted alpha therapy for cancer. Allen BJ; Raja C; Rizvi S; Li Y; Tsui W; Zhang D; Song E; Qu CF; Kearsley J; Graham P; Thompson J Phys Med Biol; 2004 Aug; 49(16):3703-12. PubMed ID: 15446799 [TBL] [Abstract][Full Text] [Related]
7. The Case for Dosimetry in Alpha-Emitter Therapy. Sgouros G J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S45-S46. PubMed ID: 31537496 [TBL] [Abstract][Full Text] [Related]
8. Radionuclide spatial distribution and dose deposition for in vitro assessments of Frelin-Labalme AM; Roger T; Falzone N; Quan Lee B; Sibson NR; Vallis KA; Bernaudin M; Valable S; Corroyer-Dulmont A Med Phys; 2020 Mar; 47(3):1317-1326. PubMed ID: 31838744 [TBL] [Abstract][Full Text] [Related]
9. Targeted Alpha Therapy: Current Clinical Applications. Guerra Liberal FDC; O'Sullivan JM; McMahon SJ; Prise KM Cancer Biother Radiopharm; 2020 Aug; 35(6):404-417. PubMed ID: 32552031 [TBL] [Abstract][Full Text] [Related]
10. Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides. Mirzadeh S J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S21-S25. PubMed ID: 31420270 [TBL] [Abstract][Full Text] [Related]
11. Clinical trials of targeted alpha therapy for cancer. Allen BJ Rev Recent Clin Trials; 2008 Sep; 3(3):185-91. PubMed ID: 18782076 [TBL] [Abstract][Full Text] [Related]
12. Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes. Palm S; Bäck T; Lindegren S; Hultborn R; Jacobsson L; Albertsson P J Nucl Med; 2018 Apr; 59(4):646-651. PubMed ID: 29175984 [TBL] [Abstract][Full Text] [Related]
13. Development of a transmission alpha particle dosimetry technique using A549 cells and a Ra-223 source for targeted alpha therapy. Al Darwish R; Staudacher AH; Li Y; Brown MP; Bezak E Med Phys; 2016 Nov; 43(11):6145. PubMed ID: 27806616 [TBL] [Abstract][Full Text] [Related]
15. Targeted alpha anticancer therapies: update and future prospects. Allen BJ; Huang CY; Clarke RA Biologics; 2014; 8():255-67. PubMed ID: 25422581 [TBL] [Abstract][Full Text] [Related]
16. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics. Huclier-Markai S; Alliot C; Varmenot N; Cutler CS; Barbet J Curr Top Med Chem; 2012; 12(23):2642-54. PubMed ID: 23339760 [TBL] [Abstract][Full Text] [Related]
17. Calculations of cellular microdosimetry parameters for alpha particles and electrons. Tung CJ; Liu CS; Wang JP; Chang SL Appl Radiat Isot; 2004 Nov; 61(5):739-43. PubMed ID: 15308137 [TBL] [Abstract][Full Text] [Related]
18. Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials. Marcu L; Bezak E; Allen BJ Crit Rev Oncol Hematol; 2018 Mar; 123():7-20. PubMed ID: 29482781 [TBL] [Abstract][Full Text] [Related]
19. Monte Carlo calculation of the maximum therapeutic gain of tumor antivascular alpha therapy. Huang CY; Oborn BM; Guatelli S; Allen BJ Med Phys; 2012 Mar; 39(3):1282-8. PubMed ID: 22380360 [TBL] [Abstract][Full Text] [Related]
20. Alpha-particles for targeted therapy. Sgouros G Adv Drug Deliv Rev; 2008 Sep; 60(12):1402-6. PubMed ID: 18541332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]